Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/16/1999 | US5883228 Functionally active regions of signal transducer and activator of transcription |
03/16/1999 | US5883227 Multiple sclerosis associated polypeptide |
03/16/1999 | US5883226 Nucleotide sequences of genes |
03/16/1999 | US5883225 Polypeptides and sequence |
03/16/1999 | US5883224 Characterization of transfer factors and methods of use |
03/16/1999 | US5883223 CD9 antigen peptides and antibodies thereto |
03/16/1999 | US5883082 Compositions and methods for preventing and treating allograft rejection |
03/16/1999 | US5883081 Isolation of novel HIV-2 proviruses |
03/16/1999 | US5883076 Inducing plant defense mechanisms; wound healing agents; genetic engineering; gene expression |
03/16/1999 | US5883075 Hypotensive agent cyclic peptides |
03/16/1999 | US5883073 Single-chain double-alpha peptide |
03/16/1999 | US5883071 Mammalian growth factor |
03/16/1999 | US5882945 Isolation, expression, immunizing and antibodies |
03/16/1999 | US5882944 Methods for G protein coupled receptor activity screening |
03/16/1999 | US5882927 Oligonucleotide inhibition of protein kinase C |
03/16/1999 | US5882926 Nucleic acid hybridization probes; genetic engineering; gene expression; diagnosing genetic disorders |
03/16/1999 | US5882925 Cdna contained in plasmids, amino acid sequences and cultures |
03/16/1999 | US5882924 Dna encodes fusion proteins |
03/16/1999 | US5882914 Nucleic acids encoding the hypoxia inducible factor-1 |
03/16/1999 | US5882899 Binds to pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide; gene expression |
03/16/1999 | US5882898 Cells and vectors with polynucleotides |
03/16/1999 | US5882897 yitJ |
03/16/1999 | US5882896 M protein |
03/16/1999 | US5882894 Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof |
03/16/1999 | US5882893 Modulation of acetylcholine responses in cells; antisense molecules; expression vectors; genetic engineering; nervous system, cardiovascular, glandular, eating, psychological, and smooth muscle disorders |
03/16/1999 | US5882892 Polypeptides and dna(rna) encoding and screening for bactericides |
03/16/1999 | US5882891 Polynucleotide segments |
03/16/1999 | US5882890 Nucleic acid and amino acid sequences of novel regulators of g-protein signaling and to the use of these sequences in the diagnosis, prevention, and treatment of disorders associated with cell proliferation and inflammation |
03/16/1999 | US5882889 Response regulator in a two component signal transduction system |
03/16/1999 | US5882887 Proteins for genetic engineering |
03/16/1999 | US5882884 Expression of proteinaceous sweeteners in yeast |
03/16/1999 | US5882880 Dna sequences and cell progression for cancer treatment |
03/16/1999 | US5882877 Cystic fibrosis treatment; genetic engineering |
03/16/1999 | US5882876 Amino acid sequences in proteins and markers of cancer cells |
03/16/1999 | US5882875 Methods for identifying multidrug resistant tumor cells |
03/16/1999 | US5882873 Human DNA sequence encoding a kidney ATP-dependent potassium channel |
03/16/1999 | US5882871 Saliva binding protein |
03/16/1999 | US5882868 Method of diagnosing spinal muscular atrophy |
03/16/1999 | US5882864 Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
03/16/1999 | US5882862 Human radioresistance/cell cycle progression gene |
03/16/1999 | US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression |
03/16/1999 | US5882858 Cloning and uses of the genetic locus BCL-6 |
03/16/1999 | US5882855 DNA encoding a human dopamine D1 receptor and uses thereof |
03/16/1999 | US5882853 Culture of t-cells for patients to form polypeptides |
03/16/1999 | US5882852 Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates |
03/16/1999 | US5882668 Maize protein for insect control |
03/16/1999 | US5882655 Serpulina hyodysenteriae vaccine comprising a hygene mutant |
03/16/1999 | US5882654 Polyvalent melanoma vaccine |
03/16/1999 | US5882653 Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof |
03/16/1999 | US5882652 Empty canine parvovirus capsids having CPV recombinant VP2 and vaccines having such capsids |
03/16/1999 | US5882650 Influenza a virus ns1 protein, or a t cell epitope thereof, is administered to the individual in an amount sufficient to stimulate the virus protective response |
03/16/1999 | US5882645 Peptide compounds |
03/16/1999 | US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae. |
03/16/1999 | US5882642 Genetically engineered transmissible hypovirulence |
03/16/1999 | CA2236363A1 Novel compound |
03/16/1999 | CA2019463C Antibiotics plusbacin |
03/16/1999 | CA2008825C Reg protein |
03/16/1999 | CA1340447C Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them |
03/16/1999 | CA1340446C Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
03/16/1999 | CA1340437C Interleukin 2 receptor and applications thereof |
03/16/1999 | CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
03/11/1999 | WO1999012038A1 Detection of measles virus-specific antibodies |
03/11/1999 | WO1999012037A1 Compositions and methods for the treatment of inflammatory bowel disease |
03/11/1999 | WO1999011824A1 An alpha-2 macroglobulin diagnostic test |
03/11/1999 | WO1999011812A1 TUMOR SUPPRESSOR GENE ON HUMAN CHROMOSOME 6q27 AND USES THEREOF |
03/11/1999 | WO1999011809A1 Conjugates that contain the homeodomain of antennapedia |
03/11/1999 | WO1999011808A1 Rna respiratory syncytial virus vaccines |
03/11/1999 | WO1999011803A1 Resistance mechanisms to ic type r/m bacteriophages of lactic acid bacteria |
03/11/1999 | WO1999011791A2 Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
03/11/1999 | WO1999011790A1 Tumor necrosis factor receptor ztnfr-6 |
03/11/1999 | WO1999011788A1 Kringle1 |
03/11/1999 | WO1999011787A1 DNA PARTICIPATING IN REGULATION OF EXPRESSION O PEBP2 αA GENE, AND USE THEREOF |
03/11/1999 | WO1999011786A1 pancpin GENE AND COMPOSITION FOR GENE THERAPY |
03/11/1999 | WO1999011785A1 Chimeric binding peptide library screening method |
03/11/1999 | WO1999011784A1 Proton gated ion channel proteins |
03/11/1999 | WO1999011783A2 T-box polypeptides |
03/11/1999 | WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
03/11/1999 | WO1999011781A1 Recombinant human erythropoietin with advantageous glycosylation profile |
03/11/1999 | WO1999011780A2 Conductine protein and a related agent for diagnosing and treating tumor illnesses |
03/11/1999 | WO1999011777A1 Methods for protein screening |
03/11/1999 | WO1999011776A1 A cell-free replication system and uses thereof |
03/11/1999 | WO1999011775A1 Mutant mhc class i molecules |
03/11/1999 | WO1999011774A1 Polypeptides comprising a coiled-coil and an addition site |
03/11/1999 | WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
03/11/1999 | WO1999011669A1 Diagnosis, prevention and treatment of diabetes |
03/11/1999 | WO1999011668A1 Dna molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby |
03/11/1999 | WO1999011667A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
03/11/1999 | WO1999011666A1 N-terminal modifications of rantes and methods of use |
03/11/1999 | WO1999011665A1 Human thrombopoietin produced by established human cell lines, process for producing the same, and medicinal compositions containing the same |
03/11/1999 | WO1999011664A1 Genetically engineered cells which express bone morphogenetic proteins |
03/11/1999 | WO1999011663A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
03/11/1999 | WO1999011662A1 Novel molecules of the tnfr-ligand-related protein family and uses thereof |
03/11/1999 | WO1999011661A1 Biomolecules comprising an elastomeric peptide |
03/11/1999 | WO1999011660A2 Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions |
03/11/1999 | WO1999011656A1 Protein composition and process for isolating a protein composition from a muscle source |
03/11/1999 | WO1999011655A1 Modular protein libraries and methods of preparation |
03/11/1999 | WO1999011654A1 Randomly generated glycopeptide combinatorial libraries |
03/11/1999 | WO1999011652A1 Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression |
03/11/1999 | WO1999011589A1 13c, 15n, 2h labeled proteins for nmr structure determinations and their preparation |
03/11/1999 | WO1999011293A1 50 human secreted proteins |